Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
TERT Promoter Variants, Older Age, and Prognosis in Papillary Thyroid Carcinoma.
Journal: JAMA otolaryngology-- head & neck surgery
Published: August 20, 2026
Revised Thyroid Differentiation Score for Risk Stratification in Papillary Thyroid Carcinoma.
Journal: JCO precision oncology
Published: July 23, 2026
A step forward for precision oncology in thyroid cancer.
Journal: The Lancet. Oncology
Published: May 18, 2026
Lenvatinib plus pembrolizumab for the treatment of patients with non-BRAF mutated anaplastic thyroid cancer: A single center, phase 2 clinical trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 16, 2026
Real-World Experience with Lenvatinib plus Pembrolizumab in Metastatic BRAF Wild-Type Anaplastic Thyroid Carcinoma.
Journal: Thyroid : official journal of the American Thyroid Association
Published: March 06, 2026
Acquired Driver Fusions as a Mechanism of Resistance to Selective RET Inhibitors in Advanced Medullary Thyroid Carcinoma.
Journal: JCO precision oncology
Published: February 20, 2026
PRECISE: A Prognostic Thyrocyte-Derived Gene Signature for Papillary Thyroid Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 24, 2025
A differentiated thyroid carcinoma-specific graded prognostic assessment for brain metastases: derivation in a 10,306-patient cohort and external validation.
Journal: Journal of neuro-oncology
Published: November 03, 2025
Prognostic Factors in Thyroid Cancer Patients With Brain Metastases: A Systematic Review and Meta-Analysis.
Journal: Thyroid : official journal of the American Thyroid Association
Published: September 16, 2025
Advances in Anaplastic Thyroid Cancer Treatment.
Journal: Endocrinology and metabolism clinics of North America
Published: July 27, 2025
Erratum: NTRK Fusion-Positive Thyroid Carcinoma: From Diagnosis to Targeted Therapy.
Journal: JCO precision oncology
Published: July 09, 2025
Adjuvant Pembrolizumab after Upfront Multimodal Therapy for Stage IVB Anaplastic Thyroid Cancer.
Journal: Thyroid : official journal of the American Thyroid Association
Published: July 03, 2025
Last Updated: 09/26/2026